Conceptual frameworks and key dimensions to support coverage decisions for vaccines

Vaccine

Volumn 33, Issue 9, 2015, Pages 1206-1217

  González Lorenzo, Marien ^a   Piatti, Alessandra ^c   Coppola, Liliana ^c   Gramegna, Maria ^c   Demicheli, Vittorio ^d   Melegaro, Alessia ^e   Tirani, Marcello ^a   Parmelli, Elena ^f,g   Auxilia, Francesco ^a   Moja, Lorenzo ^a,b   Pistotti, Vanna ^h   Zanetti, Alessandro ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^c Regione Lombardia   (Italy)

^d Servizio Regionale di Riferimento Per l'Epidemiologia   (Italy)

^e BOCCONI UNIVERSITY   (Italy)

^f DEPARTMENT OF EPIDEMIOLOGY   (Italy)

^g UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^h MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Decision aid; Decision making; Framework; Health policy; Immunisation programmes; Model; Vaccination

Indexed keywords

VACCINE;

ARTICLE; COCHRANE LIBRARY; CONCEPTUAL FRAMEWORK; DECISION MAKING; EMBASE; EVIDENCE BASED PRACTICE; HEALTH CARE POLICY; HUMAN; MEDLINE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; VACCINATION; DECISION SUPPORT SYSTEM; IMMUNIZATION; UTILIZATION;

DECISION SUPPORT TECHNIQUES; HEALTH POLICY; HUMANS; IMMUNIZATION; VACCINES;

EID: 84922925115     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.12.020     Document Type: Article

References (39)

1. Manzoli L., Flacco M.E., D'Addario M., Capasso L., De Vito C., Marzuillo C., et al. Non-publication and delayed publication of randomized trials on vaccines: survey. Br Med J 2014, 348:3058.
2. Walker C.L., Rudan I., Liu L., Nair H., Theodoratou E., Bhutta Z.A., et al. Global burden of childhood pneumonia and diarrhoea. Lancet 2013, 381(9875):1405-1416.
3. Whitney C.G., Zhou F., Singleton J., Schuchat A. Benefits from immunization during the vaccines for children program era-United States, 1994-2013. Morb Mortal Wkly Rep 2014, 63(16):352-355.
4. Hutubessy R., Henao A.M., Namgyal P., Moorthy V., Hombach J. Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal. Bio Med Cent Med. 2011, 9:55.
5. World Health Organisation. Vaccine introduction guidelines. Adding a vaccine to a national immunisation program: decision and implementation; 2010.
6. World Health Organisation. Principles and considerations for adding a vaccine to a national immunization programme. From decision to implementation and monitoring 2014.
7. CDC global health global immunization strategic framework 2011-2015. http://www.cdc.gov/globalhealth/gid/framework/
8. Treweek S., Oxman A.D., Alderson P., Bossuyt P.M., Brandt L., Brozek J., et al. Developing and Evaluating Communication Strategies to Support Informed Decisions and Practice Based on Evidence (DECIDE): protocol and preliminary results. Implement Sci 2013, 8:6.
9. Parmelli E., Amato L., Saitto C., Davoli M. DECIDE: developing and evaluating communication strategies to support informed decisions and practice based on evidence. Recenti Prog Med 2013, 104(10):522-531.
10. Guyatt G.H., Oxman A.D., Vist G.E., Kunz R., Falck-Ytter Y., Alonso-Coello P., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br Med J 2008, 336(7650):924-926.
11. Work Package 2: Policymaker and manager focussed strategies for communicating evidence-based recommendations.http://www.decide-collaboration.eu/WP2.
12. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151(4):264-269. W64.
13. Burchett H.E., Mounier-Jack S., Griffiths U.K., Mills A.J. National decision-making on adopting new vaccines: a systematic review. Health Policy Plan 2012, 27(Suppl. 2):ii62-ii76.
14. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Br Med J 2009, 339:b2700.
15. Piso B., Wild C. Decision support in vaccination policies. Vaccine 2009, 27(43):5923-5928.
16. Tapia-Conyer R., Betancourt-Cravioto M., Saucedo-Martinez R., Motta-Murguia L., Gallardo-Rincon H. Strengthening vaccination policies in Latin America: an evidence-based approach. Vaccine 2013, 31(37):3826-3833.
17. Ahmed F., Temte J.L., Campos-Outcalt D., Schunemann H.J. Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC). Vaccine 2011, 29(49):9171-9176.
18. Blecher M.S., Meheus F., Kollipara A., Hecht R., Cameron N.A., Pillay Y., et al. Financing vaccinations-the South African experience. Vaccine 2012, 30(Suppl. 3):SC79-SC86.
19. Brooks A., Ba-Nguz A. Country planning for health interventions under development: lessons from the malaria vaccine decision-making framework and implications for other new interventions. Health Policy Plan 2012, 27(Suppl. 2):ii50-ii61.
20. Duclos P., Durrheim D.N., Reingold A.L., Bhutta Z.A., Vannice K., Rees H. Developing evidence-based immunization recommendations and GRADE. Vaccine 2012, 31(1):12-19.
21. Ngcobo N.J., Cameron N.A. The decision making process on new vaccines introduction in South Africa. Vaccine 2012, 30(Suppl. 3):SC9-SC13.
22. Milstien J., Cardenas V., Cheyne J., Brooks A. WHO policy development processes for a new vaccine: case study of malaria vaccines. Malar J 2010, 9:182.
23. Levine O.S., Hajjeh R., Wecker J., Cherian T., O'Brien K.L., Knoll M.D., et al. A policy framework for accelerating adoption of new vaccines. Hum Vaccine 2010, 6(12):1021-1024.
24. Makinen M., Kaddar M., Molldrem V., Wilson L. New vaccine adoption in lower-middle-income countries. Health Policy Plan 2012, 27(Suppl. 2):ii39-ii49.
25. Cho H.Y. An overview of the national immunization policy making process: the role of the Korea expert committee on immunization practices. Korean J Pediatr 2012, 55(1):1-5.
26. Bryson M., Duclos P., Jolly A., Bryson J. A systematic review of national immunization policy making processes. Vaccine 2010, 28(Suppl. 1):SA6-SA12.
27. Piatti A. Decisional aid tool for vaccine policy in Lombardia, Italy 2011, University of Milan, Milan.
28. Vogel J.P., Oxman A.D., Glenton C., Rosenbaum S., Lewin S., Gulmezoglu A.M., et al. Policymakers' and other stakeholders' perceptions of key considerations for health system decisions and the presentation of evidence to inform those considerations: an international survey. Health Res Policy Syst 2013, 11:19.
29. Hamers R.L., Schuurman R., van Vugt M., Derdelinckx I., Rinke de Wit T.F. AIDS treatment in Africa: the risk of antiretroviral resistance. Ned Tijdschrift Geneeskd 2007, 151(48):2666-2671.
30. Burns J.E., Mitrovich R.C., Jauregui B., Matus C.R., Andrus J.K. Descriptive analysis of immunization policy decision making in the Americas. Rev Panam Salud Publica 2009, 26(5):398-404.
31. Andrus J.K., Toscano C.M., Lewis M., Oliveira L., Ropero A.M., Davila M., et al. A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac initiative. Public Health Rep 2007, 122(6):811-816.
32. Beutels P., Jit M. A brief history of economic evaluation for human papillomavirus vaccination policy. Sex Health 2010, 7(3):352-358.
33. Haas M., Ashton T., Blum K., Christiansen T., Conis E., Crivelli L., et al. Drugs, sex, money and power: an HPV vaccine case study. Health Policy 2009, 92(2-3):288-295.
34. Gotzsche P.C., Ioannidis J.P. Content area experts as authors: helpful or harmful for systematic reviews and meta-analyses?. Br Med J 2012, 345:e7031.
35. Ioannidis J.P., Evans S.J., Gotzsche P.C., O'Neill R.T., Altman D.G., Schulz K., et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Int Med 2004, 141(10):781-788.
36. Ashbaugh A.R., Herbert C.F., Saimon E., Azoulay N., Olivera-Figueroa L., Brunet A. The decision to vaccinate or not during the H1N1 pandemic: selecting the lesser of two evils?. Plos One 2013, 8(3):e58852.
37. Fedson D.S., Opal S.M. The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threat. Hum Vaccines Immunother 2013, 9(5):977-986.
38. Kennedy C., Gray Brunton C., Hogg R. Just that little bit of doubt': Scottish parents', teenage girls' and health professionals' views of the MMR, H1N1 and HPV vaccines. Int J Behav Med 2014, 21(1):3-10.
39. Fidler D.P. Negotiating equitable access to influenza vaccines: global health diplomacy and the controversies surrounding avian influenza H5N1 and pandemic influenza H1N1. Plos Med 2010, 7(5):e1000247.